NSE - Delayed Quote INR
Brooks Laboratories Limited (BROOKS.NS)
139.83
-7.36
(-5.00%)
At close: April 25 at 3:25:45 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
-96,806
-144,902
-374,409
44,588
Investing Cash Flow
--
1,822
4,949
-249,085
-51,296
Financing Cash Flow
--
96,007
114,136
640,706
11,588
End Cash Position
--
1,255
232
26,050
8,839
Capital Expenditure
--
-4,390
-4,675
-232,152
-56,138
Issuance of Capital Stock
--
112,672
--
--
--
Free Cash Flow
--
-101,196
-149,577
-606,561
-11,550
3/31/2021 - 9/5/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THEMISMED.NS Themis Medicare Limited
133.54
-3.60%
ORCHPHARMA.NS Orchid Pharma Limited
808.55
-4.14%
SHILPAMED.NS Shilpa Medicare Limited
680.85
-5.67%
SPARC.NS Sun Pharma Advanced Research Company Limited
149.77
-3.37%
NEULANDLAB.NS Neuland Laboratories Limited
12,300.00
-5.96%
GRANULES.NS Granules India Limited
452.55
-4.74%
WOCKPHARMA.NS Wockhardt Limited
1,397.60
-4.61%
MOREPENLAB.NS Morepen Laboratories Limited
58.82
-5.46%
DIVISLAB.NS Divi's Laboratories Limited
6,012.50
-3.27%